|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo T, Kong J, Liu Y, Li Z, Xia J, Zhang
Y, Zhao S, Li F, Li J and Gu C: Transcriptional activation of NANOG
by YBX1 promotes lung cancer stem-like properties and metastasis.
Biochem Biophys Res Commun. 487:153–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL, Wu YL and Paz-Ares L: Lung cancer:
Current therapies and new targeted treatments. Lancet. 389:299–311.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang K, Gong Q, Zhan Y, Chen B, Yin T, Lu
Y, Zhang Y, Wang H, Ke J, Du B, et al: Blockage of autophagic flux
and induction of mitochondria fragmentation by paroxetine
hydrochloride in lung cancer cells promotes apoptosis via the
ROS-MAPK pathway. Front Cell Dev Biol. 7:3972019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lathia JD and Liu H: Overview of cancer
stem cells and stemness for community oncologists. Target Oncol.
12:387–399. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valent P, Bonnet D, De Maria R, Lapidot T,
Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi
G, et al: Cancer stem cell definitions and terminology: The devil
is in the details. Nat Rev Cancer. 12:767–775. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Magee JA, Piskounova E and Morrison SJ:
Cancer stem cells: Impact, heterogeneity, and uncertainty. Cancer
Cell. 21:283–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yue Y, Xia L, Xu S, Wang C, Wang X, Lu W
and Xie X: SURF4 maintains stem-like properties via BIRC3 in
ovarian cancer cells. J Gynecol Oncol. 31:e462020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jimenez-Hernandez LE, Vazquez-Santillan K,
Castro-Oropeza R, Martinez-Ruiz G, Muñoz-Galindo L, Gonzalez-Torres
C, Cortes-Gonzalez CC, Victoria-Acosta G, Melendez-Zajgla J and
Maldonado V: NRP1-Positive lung cancer cells possess
tumor-initiating properties. Oncol Rep. 39:349–357. 2018.PubMed/NCBI
|
|
14
|
Yang S, Chen T, Huang L, Xu S, Cao Z,
Zhang S, Xu J, Li Y, Yue Y, Lu W, et al: High-Risk human
papillomavirus E7 maintains stemness via APH1B in cervical cancer
stem-cell like cells. Cancer Manag Res. 11:9541–9552. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davis FM, Stewart TA, Thompson EW and
Monteith GR: Targeting EMT in cancer: Opportunities for
pharmacological intervention. Trends Pharmacol Sci. 35:479–488.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abu-Elheiga L, Jayakumar A, Baldini A,
Chirala SS and Wakil SJ: Human acetyl-CoA carboxylase:
Characterization, molecular cloning, and evidence for two isoforms.
Proc Natl Acad Sci USA. 92:4011–4015. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Zhou AY, Brooks M, Reinhard F, Zhang CC, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu GT: Pharmacological actions and
clinical use of fructus schizandrae. Chin Med J (Engl).
102:740–749. 1989.PubMed/NCBI
|
|
20
|
Lee MY, Seo CS, Lee NH, Ha H, Lee JA, Lee
H, Lee Ky and Shin HK: Anti-Asthmatic effect of schizandrin on
OVA-induced airway inflammation in a murine asthma model. Int
Immunopharmacol. 10:1374–1379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nasser MI, Han T, Adlat S, Tian Y and
Jiang N: Inhibitory effects of schisandrin B on human prostate
cancer cells. Oncol Rep. 41:677–685. 2019.PubMed/NCBI
|
|
22
|
Dai X, Yin C, Guo G, Zhang Y, Zhao C, Qian
J, Wang O, Zhang X and Liang G: Schisandrin B exhibits potent
anticancer activity in triple negative breast cancer by inhibiting
STAT3. Toxicol Appl Pharmacol. 358:110–119. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang Y, Zhang Q, Bao J, Du C, Wang J,
Tong Q and Liu C: Schisandrin B inhibits the proliferation and
invasion of glioma cells by regulating the HOTAIR-micoRNA-125a-mTOR
pathway. Neuroreport. 28:93–100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv XJ, Zhao LJ, Hao YQ, Su ZZ, Li JY, Du
YW and Zhang J: Schisandrin B inhibits the proliferation of human
lung adenocarcinoma A549 cells by inducing cycle arrest and
apoptosis. Int J Clin Exp Med. 8:6926–6936. 2015.PubMed/NCBI
|
|
25
|
Zhuang W, Li Z, Dong X, Zhao N, Liu Y,
Wang C and Chen J: Schisandrin B inhibits TGF-β1-induced
epithelial-mesenchymal transition in human A549 cells through
epigenetic silencing of ZEB1. Exp Lung Res. 45:157–166. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Meng X, Zhang D, Xu X, Li S and Li
Y: Ginkgolic acid suppresses the invasion of HepG2 cells via
downregulation of HGF/c-met signaling. Oncol Rep. 41:369–376.
2019.PubMed/NCBI
|
|
27
|
Suresh R, Ali S, Ahmad A, Philip PA and
Sarkar FH: The role of cancer stem cells in recurrent and
drug-resistant lung cancer. Adv Exp Med Biol. 890:57–74. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang MS, Ryu E, Lee SW, Park J, Ha NY, Ra
JS, Kim YJ, Kim J, Abdel-Rahman M, Park SH, et al: Regulation of
PCNA cycling on replicating DNA by RFC and RFC-like complexes. Nat
Commun. 10:24202019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Capp JP: Cancer stem cells: From
historical roots to a new perspective. J Oncol. 2019:51892322019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Najafi M, Farhood B and Mortezaee K:
Cancer stem cells (CSCs) in cancer progression and therapy. J Cell
Physiol. 234:8381–8395. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen C, Zhao S, Karnad A and Freeman JW:
The biology and role of CD44 in cancer progression: therapeutic
implications. J Hematol Oncol. 11:642018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang D, Lu P, Zhang H, Luo M, Zhang X, Wei
X, Gao J, Zhao Z and Liu C: Oct-4 and nanog promote the
epithelial-mesenchymal transition of breast cancer stem cells and
are associated with poor prognosis in breast cancer patients.
Oncotarget. 5:10803–10815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Althobiti M, Muftah AA, Aleskandarany MA,
Joseph C, Toss MS, Green A and Rakha E: The prognostic significance
of BMI1 expression in invasive breast cancer is dependent on its
molecular subtypes. Breast Cancer Res Treat. 182:581–589. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McCoy MG, Nyanyo D, Hung CK, Goerger JP,
Zipfel WR, Williams RM, Nishimura N and Fischbach C: Endothelial
cells promote 3D invasion of GBM by IL-8-dependent induction of
cancer stem cell properties. Sci Rep. 9:90692019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang F, Ma L, Zhang Z, Liu X, Gao H,
Zhuang Y, Yang P, Kornmann M, Tian X and Yang Y: Hedgehog signaling
regulates epithelial-mesenchymal transition in pancreatic cancer
stem-like cells. J Cancer. 7:408–417. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang Y, Zhang Q, Bao J, Du C, Wang J,
Tong Q and Liu C: Schisandrin B suppresses glioma cell metastasis
mediated by inhibition of mTOR/MMP-9 signal pathway. Biomed
Pharmacother. 74:77–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiang SS, Wang XA, Li HF, Shu YJ, Bao RF,
Zhang F, Cao Y, Ye YY, Weng H and Wu WG: Schisandrin B induces
apoptosis and cell cycle arrest of gallbladder cancer cells.
Molecules. 19:13235–13250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu XN, Zhang CY, Jin XD, Li YZ, Zheng XZ
and Li L: Inhibitory effect of schisandrin B on gastric cancer
cells in vitro. World J Gastroenterol. 13:6506–6511. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Z, Zhang B, Liu K, Ding Z and Hu X:
Schisandrin B attenuates cancer invasion and metastasis via
inhibiting epithelial-mesenchymal transition. PLoS One.
7:e404802012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu B, Cao W and Ma H: Knockdown of lncRNA
LSINCT5 suppresses growth and metastasis of human glioma cells via
up-regulating miR-451. Artif Cells Nanomed Biotechnol.
47:2507–2515. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Serramito-Gomez I, Boada-Romero E,
Slowicka K, Vereecke L, Van Loo G and Pimentel-Muiños FX: The
anti-inflammatory protein TNFAIP3/A20 binds the WD40 domain of
ATG16L1 to control the autophagic response, NFKB/NF-kappaB
activation and intestinal homeostasis. Autophagy. 15:1657–1659.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kumar M, Allison DF, Baranova NN, Wamsley
JJ, Katz AJ, Bekiranov S, Bekiranov S, Jones DR and Mayo MW: NF-κB
regulates mesenchymal transition for the induction of non-small
cell lung cancer initiating cells. PLoS One. 8:e685972013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Murayama T, Nakaoku T, Enari M, Nishimura
T, Tominaga K, Nakata A, Tojo A, Sugano S, Kohno T and Gotoh N:
Oncogenic fusion gene CD74-NRG1 confers cancer stem cell–like
properties in lung cancer through a IGF2 autocrine/paracrine
circuit. Cancer Res. 76:9742016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zakaria N, Yusoff NM, Zakaria Z, Widera D
and Yahaya BH: Inhibition of NF-κB signaling reduces the stemness
characteristics of lung cancer stem cells. Front Oncol. 8:1662018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Perkins ND: Integrating cell-signalling
pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hsieh KY, Wei CK and Wu CC: YC-1 prevents
tumor-associated tissue factor expression and procoagulant activity
in hypoxic conditions by inhibiting p38/NF-κB signaling pathway.
Int J Mol Sci. 20:2442019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li T, Wu YN, Wang H, Ma JY, Zhai SS and
Duan J: Dapk1 improves inflammation, oxidative stress and autophagy
in LPS-induced acute lung injury via p38MAPK/NF-κB signaling
pathway. Mol Immunol. 120:13–22. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ghosh S and Hayden MS: New regulators of
NF-κB in inflammation. Nat Rev Immunol. 8:837–848. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tian X, Wang Y, Li S, Yue W and Tian H:
ZHX2 inhibits proliferation and promotes apoptosis of human lung
cancer cells through targeting p38MAPK pathway. Cancer Biomark.
27:75–84. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kwan HY, Niu X, Dai W, Tong T, Chao X, Su
T, Chan CL, Lee KC, Fu X, Yi H and Yu H: Lipidomic-Based
investigation into the regulatory effect of schisandrin B on
palmitic acid level in non-alcoholic steatotic livers. Sci Rep.
5:91142015. View Article : Google Scholar : PubMed/NCBI
|
